From 1 September 2024, Australian patients prescribed Pegasys® will predominantly be able to access this treatment through the new dedicated Pegasys®   Home Delivery Program. This program is delivered by Echo Therapeutics (the sponsor of Pegasys® in Australia) through its EchoCare™ service, in partnership with JustMeds – a local specialist medicines delivery provider. This is initially a short- to medium-term solution to make sure Australian patients prescribed Pegasys® can continue to access treatment when needed. 

​

To find our more information about Pegasys and relevant information to wholesalers accessing Pegasys, please click on the below updates or contact 1300 84 83 28 to speak to the Echo Therapeutics Customer Support team.